Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Justin S. Waters"'
Autor:
Roger A'Hern, Tim Eisen, M. G. James, S Hackett, Justin S. Waters, Martin Gore, C Moss, Lynda Pyle
Publikováno v:
British Journal of Cancer
We report a single institution phase II study of gemcitabine 1200 mg m(-2) i.v. on days 1 and 8 and capecitabine 1300 mg m(-2) twice daily on days 1-14 of each 3-week cycle in patients with metastatic renal carcinoma. Patients had a WHO performance s
Autor:
M.E. Hill, Justin S. Waters, A. R. Norman, Gina Brown, Jacqui Oates, David Cunningham, L. Assersohn, C. Ward
Publikováno v:
Annals of Oncology. 15:64-69
Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma Background: The purpose of this study was to assess the efficacy and toxicity of irinotecan and 5-fl
Autor:
S. A. Haque, Tracey Murray, Ian Chau, M. Allen, P.A. Trott, G. Querci della Rovere, L Bishop, Peter Rhys-Evans, A. Wotherspoon, M T Kelleher, Gina Brown, A. R. Norman, D D Cunningham, Justin S. Waters
Publikováno v:
British Journal of Cancer
Lymphadenopathy is common, affecting patients of all ages. The current referral pattern for investigating patients with lymphadenopathy varies widely with no universally practised pathway. Our institution set up a lymph node diagnostic clinic (LNDC)
Autor:
Anwar R. Padhani, Jacqui Oates, M.E. Hill, S Falk, Justin S. Waters, A Hill, David Cunningham, Diana Tait, F. Lofts, A. R. Norman
Publikováno v:
Annals of Oncology. 13:1763-1770
A multicentre phase II trial of primary chemotherapy with cisplatin and protracted venous infusion 5-fluorouracil followed by chemoradiation in patients with carcinoma of the oesophagus Background: We undertook a multicentre phase II trial to evaluat
Publikováno v:
British Journal of Cancer
The purpose of this study was to evaluate the activity and safety of oxaliplatin and protracted venous infusion of 5-fluorouracil (PVI 5-FU) in patients with advanced or relapsed 5-FU pretreated colorectal cancer. 38 patients with advanced or metasta
Autor:
Andrew Webb, Justin S. Waters, Florence I. Raynaud, F Di Stefano, Paul A. Clarke, David Cunningham, Finbarr E. Cotter
Publikováno v:
Europe PubMed Central
PURPOSE: To evaluate the pharmacokinetics and toxicity of an antisense oligonucleotide targeting bcl-2 in patients with non-Hodgkin’s lymphoma (NHL) and to determine efficacy using clinical and biologic end points. PATIENTS AND METHODS: Twenty-one
Autor:
David B Smith, Russell D. Petty, Gary Middleton, Sarah Slater, Alicia Okines, William H. Allum, Marcia Hall, L.C. Thompson, Ruth E Langley, Chris Plummer, L. Stevenson, Jane M Blazeby, Timothy Iveson, David Cunningham, S Falk, Matthew T. Seymour, Justin S. Waters, D. Ford, M Griffin, L. Evans, Fraser Coxon, Sally P. Stenning
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 24(3)
Peri-operative chemotherapy and surgery is a standard treatment of localised oesophagogastric adenocarcinoma; however, the outcomes remain poor.ST03 is a multicentre, randomised, phase II/III study comparing peri-operative ECX with or without bevaciz
Autor:
Ian Chau, Mark A. Hill, Gary Middleton, P J Ross, Jacqui Oates, C. Topham, R Katopodis, A. R. Norman, Justin S. Waters, G. Stewart, David Cunningham
Publikováno v:
British Journal of Cancer
Elderly patients are recommended to have a reduced starting dose (300 mg m(-2) once every 3 weeks) of irinotecan monotherapy. The aims of this analysis are to compare toxicity and survival according to age, performance status (PS), gender and prior r
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 22(12)
Purpose To identify baseline prognostic factors and assess whether pretreatment quality of life (QoL) predicts survival in patients with locally advanced or metastatic esophago-gastric cancer. Patients and Methods Between 1992 and 2001, 1,080 patient
Autor:
Justin S. Waters, A. Norton, Stanley W. Ashley, Mary O'Brien, Ian E. Smith, Tim Eisen, K. Priest, P J Ross
Publikováno v:
British Journal of Cancer
To examine whether weight loss at presentation influences outcome in patients who received chemotherapy for lung cancer or mesothelioma. Multivariate analysis of prospectively collected data 1994-2001. Data were available for age, gender, performance